Processa Pharmaceuticals, Inc. (PCSA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 301 | 0 | 0 | 0 | 0 | 301 | 0 | 0 | 0 | 140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -301 | 0 | 0 | 0 | 0 | -301 | 0 | 0 | 0 | -140 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | -115% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 3.33M | 3.7M | 3.49M | 3.95M | 2.85M | 2.73M | 3.42M | 3.08M | 2.81M | 2.47M | 2.17M | 2.71M | 4.11M | 13.07M | 6.06M | 5.17M | 3.23M | 3.37M | 3.11M | 3.46M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.52M | 1.59M | 1.83M | 1.5M | 1.26M | 1.02M | 1.14M | 1.35M | 1.27M | 1.15M | 1.02M | 1.03M | 2.48M | 2.63M | 2.92M | 2.03M | 1.18M | 1.3M | 1.34M | 1.33M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.81M | 2.11M | 1.66M | 2.45M | 1.59M | 1.71M | 2.29M | 1.73M | 1.54M | 1.32M | 1.15M | 1.69M | 1.63M | 3.17M | 3.14M | 3.14M | 2.04M | 2.07M | 1.72M | 1.61M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 50.95K | 515.63K |
| Operating Income | -3.33M | -3.7M | -3.49M | -3.95M | -2.85M | -2.73M | -3.42M | -3.08M | -2.81M | -2.47M | -2.17M | -2.71M | -4.11M | -13.07M | -6.06M | -5.17M | -3.23M | -3.37M | -3.11M | -3.46M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -17.01% | -35.37% | -1.87% | -28.19% | -1.33% | -10.74% | -58% | -13.54% | 31.57% | 81.1% | 64.21% | 47.51% | -27.16% | -287.88% | -94.67% | -49.48% | -47.21% | 67.58% | -5.27% | -331.4% |
| EBITDA | -3.33M | -3.7M | -3.49M | -3.95M | -2.85M | -2.73M | -3.42M | -3.08M | -2.81M | -2.47M | -2.17M | -2.71M | -4.11M | -12.87M | -5.86M | -4.97M | -3.03M | -3.17M | -2.92M | -3.26M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -17.01% | -35.37% | -1.87% | -28.18% | -1.33% | -10.74% | -58% | -13.54% | 31.57% | 80.81% | 63.01% | 45.43% | -35.43% | -305.78% | -100.98% | -52.55% | -52.04% | 68.88% | -5.85% | -442.55% |
| D&A (Non-Cash Add-back) | 301 | 301 | 301 | 301 | 301 | 301 | 203 | 139 | 139 | 140 | 82 | 0 | 0 | 197.12K | 197.12K | 197.12K | 197.12K | 197.12K | 195.7K | 198.83K |
| EBIT | -3.33M | -3.7M | -3.49M | -3.95M | -2.85M | -2.73M | -3.42M | -3.08M | -2.81M | -2.47M | -2.17M | -2.71M | -4.11M | -5.8M | -6.06M | -5.17M | -3.23M | -3.37M | -3.06M | -3.29M |
| Net Interest Income | 13.86K | 35.49K | 52K | 16.86K | 12.59K | 6.02K | 40.15K | 71.7K | 83.22K | 64.52K | 85.66K | 102K | 83.46K | 55.53K | 36.71K | 7.38K | 1.58K | 3.46K | 1.77K | 1.81K |
| Interest Income | 13.86K | 35.49K | 52K | 16.86K | 12.59K | 6.02K | 40.15K | 71.7K | 83.22K | 64.52K | 85.66K | 102K | 83.46K | 55.53K | 36.71K | 7.38K | 1.58K | 3.46K | 1.77K | 1.81K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -45.97K | 342.95K | 52.27K | 16.86K | 12.59K | 6.02K | 40.15K | 71.7K | 83.22K | 64.52K | 85.66K | 101.9K | 83.46K | 55.53K | 36.71K | 7.38K | 1.58K | 3.46K | 1.77K | 165.59K |
| Pretax Income | -3.38M | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M | -3.38M | -3.01M | -2.73M | -2.4M | -2.08M | -2.61M | -4.02M | -13.01M | -6.02M | -5.16M | -3.23M | -3.37M | -3.11M | -3.29M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -181.75K | -122.44K | -137.17K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5.4% | 3.94% | 4.16% |
| Net Income | -3.38M | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M | -3.38M | -3.01M | -2.73M | -2.4M | -2.08M | -2.61M | -4.02M | -13.01M | -6.02M | -5.16M | -3.23M | -3.18M | -2.99M | -3.16M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -19.15% | -23.1% | -1.53% | -30.68% | -3.96% | -13.46% | -62.57% | -15.22% | 32.21% | 81.52% | 65.42% | 49.41% | -24.63% | -308.7% | -101.54% | -63.58% | -53.71% | 67.29% | 2.74% | -330.46% |
| Net Income (Continuing) | -3.38M | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M | -3.38M | -3.01M | -2.73M | -2.4M | -2.08M | -2.61M | -4.02M | -13.01M | -6.02M | -5.16M | -3.23M | -3.18M | -2.99M | -3.16M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.29 | -1.31 | -1.81 | -6.25 | -7.44 | -18.45 | -25.75 | -25.25 | -27.75 | -32.50 | -38.50 | -48.50 | -88.25 | -1045.00 | -185.00 | -160.00 | -100.00 | -100.00 | -95.00 | -100.00 |
| EPS Growth % | 82.66% | 92.9% | 92.97% | 75.25% | 73.19% | 43.23% | 33.12% | 47.94% | 68.56% | 96.89% | 79.19% | 69.69% | 11.75% | -945% | -94.74% | -60% | -42.86% | 71.01% | 65.45% | -53.85% |
| EPS (Basic) | -1.29 | -1.31 | -1.81 | -6.25 | -7.44 | -18.45 | -25.75 | -25.25 | -27.75 | -32.50 | -38.50 | -48.50 | -88.25 | -1045.00 | -185.00 | -160.00 | -100.00 | -100.00 | -95.00 | -100.00 |
| Diluted Shares Outstanding | 2.62M | 2.57M | 1.9M | 622.77K | 381.07K | 147.87K | 131.04K | 119.33K | 98.66K | 51.44K | 54.01K | 53.87K | 45.54K | 32.07K | 32.4K | 31.88K | 31.66K | 31.4K | 31.06K | 30.81K |
| Basic Shares Outstanding | 2.62M | 2.57M | 1.9M | 622.77K | 381.07K | 147.87K | 131.04K | 119.33K | 98.66K | 51.44K | 54.01K | 53.87K | 45.54K | 32.07K | 32.4K | 31.88K | 31.66K | 31.4K | 31.06K | 30.81K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |